Mostrar el registro sencillo del ítem

dc.creatorKoureas M., Kalompatsios D., Amoutzias G.D., Hadjichristodoulou C., Gourgoulianis K., Tsakalof A.en
dc.date.accessioned2023-01-31T08:45:30Z
dc.date.available2023-01-31T08:45:30Z
dc.date.issued2021
dc.identifier10.3390/molecules26092609
dc.identifier.issn14203049
dc.identifier.urihttp://hdl.handle.net/11615/75317
dc.description.abstractThe aim of the present study was to compare the efficiency of targeted and untargeted breath analysis in the discrimination of lung cancer (Ca+) patients from healthy people (HC) and patients with benign pulmonary diseases (Ca−). Exhaled breath samples from 49 Ca+ patients, 36 Ca− patients and 52 healthy controls (HC) were analyzed by an SPME–GC–MS method. Untargeted treatment of the acquired data was performed with the use of the web-based platform XCMS Online combined with manual reprocessing of raw chromatographic data. Machine learning methods were applied to estimate the efficiency of breath analysis in the classification of the participants. Results: Untargeted analysis revealed 29 informative VOCs, from which 17 were identified by mass spectra and retention time/retention index evaluation. The untargeted analysis yielded slightly better results in discriminating Ca+ patients from HC (accuracy: 91.0%, AUC: 0.96 and accuracy 89.1%, AUC: 0.97 for untargeted and targeted analysis, respectively) but significantly improved the efficiency of discrimination between Ca+ and Ca− patients, increasing the accuracy of the classification from 52.9 to 75.3% and the AUC from 0.55 to 0.82. Conclusions: The untargeted breath analysis through the inclusion and utilization of newly identified compounds that were not considered in targeted analysis allowed the discrimination of the Ca+ from Ca− patients, which was not achieved by the targeted approach. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.en
dc.language.isoenen
dc.sourceMoleculesen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85105493484&doi=10.3390%2fmolecules26092609&partnerID=40&md5=8487e8de6709ada2ac8e1fa3decc6f0d
dc.subjectbiological markeren
dc.subjectvolatile organic compounden
dc.subjectageden
dc.subjectbreath analysisen
dc.subjectcase control studyen
dc.subjectdifferential diagnosisen
dc.subjectdisease predispositionen
dc.subjectexhalationen
dc.subjectfemaleen
dc.subjecthumanen
dc.subjectlung diseaseen
dc.subjectlung tumoren
dc.subjectmachine learningen
dc.subjectmaleen
dc.subjectmass fragmentographyen
dc.subjectmetabolismen
dc.subjectmiddle ageden
dc.subjectproceduresen
dc.subjectrisk factoren
dc.subjectAgeden
dc.subjectBiomarkersen
dc.subjectBreath Testsen
dc.subjectCase-Control Studiesen
dc.subjectDiagnosis, Differentialen
dc.subjectDisease Susceptibilityen
dc.subjectExhalationen
dc.subjectFemaleen
dc.subjectGas Chromatography-Mass Spectrometryen
dc.subjectHumansen
dc.subjectLung Diseasesen
dc.subjectLung Neoplasmsen
dc.subjectMachine Learningen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectRisk Factorsen
dc.subjectVolatile Organic Compoundsen
dc.subjectMDPI AGen
dc.titleComparison of targeted and untargeted approaches in breath analysis for the discrimination of lung cancer from benign pulmonary diseases and healthy personsen
dc.typejournalArticleen


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem